rTMS of the left dorsolateral prefrontal cortex modulates dopamine release in the ipsilateral anterior cingulate cortex and orbitofrontal cortex.
BACKGROUND
Brain dopamine is implicated in the regulation of movement, attention, reward and learning and plays an important role in Parkinson's disease, schizophrenia and drug addiction. Animal experiments have demonstrated that brain stimulation is able to induce significant dopaminergic changes in extrastriatal areas. Given the up-growing interest of non-invasive brain stimulation as potential tool for treatment of neurological and psychiatric disorders, it would be critical to investigate dopaminergic functional interactions in the prefrontal cortex and more in particular the effect of dorsolateral prefrontal cortex (DLPFC) (areas 9/46) stimulation on prefrontal dopamine (DA).


RESULTS
Healthy volunteers were studied with a high-affinity DA D2-receptor radioligand, [(11)C]FLB 457-PET following 10 Hz repetitive transcranial magnetic stimulation (rTMS) of the left and right DLPFC. rTMS on the left DLPFC induced a significant reduction in [(11)C]FLB 457 binding potential (BP) in the ipsilateral subgenual anterior cingulate cortex (ACC) (BA 25/12), pregenual ACC (BA 32) and medial orbitofrontal cortex (BA 11). There were no significant changes in [(11)C]FLB 457 BP following right DLPFC rTMS.


CONCLUSIONS
To our knowledge, this is the first study to provide evidence of extrastriatal DA modulation following acute rTMS of DLPFC with its effect limited to the specific areas of medial prefrontal cortex. [(11)C]FLB 457-PET combined with rTMS may allow to explore the neurochemical functions of specific cortical neural networks and help to identify the neurobiological effects of TMS for the treatment of different neurological and psychiatric diseases.
Cho
Sang Soo
SS
Toronto Western Research Institute and Hospital, UHN, University of Toronto, Toronto, Canada.
Strafella
Antonio P
AP
D000328:Adult; D004298:Dopamine / Q000378:metabolism*; D005260:Female; D006179:Gyrus Cinguli / Q000000981:diagnostic imaging / Q000378:metabolism*; D006801:Humans; D008297:Male; D049268:Positron-Emission Tomography; D017397:Prefrontal Cortex / Q000000981:diagnostic imaging / Q000378:metabolism / Q000502:physiology*; D012016:Reference Values; D050781:Transcranial Magnetic Stimulation
D004298:Dopamine
Brain. 2003 Dec;126(Pt 12):2609-15
12937078
Exp Brain Res. 2000 Jul;133(1):55-65
10933210
Nat Rev Neurosci. 2003 Jan;4(1):37-48
12511860
J Neurochem. 1996 Feb;66(2):589-98
8592128
Eur J Neurosci. 2005 Dec;22(11):2946-52
16324129
J Comp Neurol. 1987 Aug 8;262(2):271-89
3624555
Ann Clin Psychiatry. 2005 Jul-Sep;17(3):153-9
16433057
Encephale. 2007 Mar-Apr;33(2):126-34
17675907
J Psychiatr Res. 2006 Jun;40(4):307-14
16259998
J Neurosci. 2006 Jun 14;26(24):6469-72
16775134
Neurosci Lett. 1993 Jul 9;157(1):53-6
7901810
Biol Psychiatry. 2007 Dec 1;62(11):1208-16
17573044
Cereb Cortex. 1992 Nov-Dec;2(6):435-43
1477524
Neuroimage. 2007 Aug 15;37(2):579-88
17604651
Proc Natl Acad Sci U S A. 2001 Mar 27;98(7):4259-64
11259662
Brain Res. 1993 Apr 23;609(1-2):237-43
8099521
Pain. 2004 May;109(1-2):86-93
15082129
J Neurochem. 1995 Sep;65(3):1407-10
7643120
J Neurosci. 2000 May 15;20(10):3864-73
10804226
Neurology. 2003 Jun 10;60(11):1844-6
12796547
Neuroscience. 1991;41(1):1-24
1676137
Trends Neurosci. 1990 Jul;13(7):272-6
1695402
J Cereb Blood Flow Metab. 1999 Oct;19(10):1164-73
10532641
J Neural Transm (Vienna). 1997;104(2-3):191-7
9203081
Brain Res. 1996 Mar 4;711(1-2):1-9
8680850
Nat Rev Neurosci. 2001 Oct;2(10):685-94
11584306
J Clin Neurophysiol. 1998 Jul;15(4):333-43
9736467
Addiction. 2000 Aug;95 Suppl 2:S119-28
11002907
Neuroimage. 2006 Jun;31(2):641-8
16497518
Eur J Neurosci. 2000 Oct;12(10):3713-20
11029641
Neuroimage. 1996 Dec;4(3 Pt 1):223-35
9345513
J Pharmacol Exp Ther. 1998 Apr;285(1):143-54
9536004
Prog Neurobiol. 2002 May;67(1):53-83
12126656
J Neurosci. 2001 Jan 15;21(2):700-12
11160449
J Neurol Sci. 2004 Jan 15;217(1):73-81
14675613
Eur J Neurol. 2003 Sep;10(5):567-72
12940840
J Cereb Blood Flow Metab. 2007 Feb;27(2):369-77
16685253
Clin Neurophysiol. 2001 Nov;112(11):2015-21
11682339
Neuropharmacology. 2002 Jul;43(1):101-9
12213264
Psychiatry Res. 2007 Dec 15;156(3):251-5
17993266
Neuron. 2005 Mar 3;45(5):651-60
15748841
J Neuropsychiatry Clin Neurosci. 2007 Spring;19(2):179-86
17431065
Cereb Cortex. 1998 Jun;8(4):321-45
9651129
J Neurosci. 2001 Aug 1;21(15):RC157
11459878
Neuroscientist. 2001 Aug;7(4):293-302
11488395
Nat Rev Neurosci. 2001 Jun;2(6):417-24
11389475
Psychopharmacology (Berl). 1997 Oct;133(4):396-404
9372541
J Neurosci. 1991 Sep;11(9):2694-702
1880545
Synapse. 2004 Oct;54(1):46-63
15300884
Science. 2001 Aug 10;293(5532):1164-6
11498597
Neuropsychopharmacology. 2002 Oct;27(4):638-45
12377400
J Neurosci. 2005 Mar 9;25(10):2471-7
15758155
Eur J Neurosci. 2008 Nov;28(10):2147-55
19046396
Neuroimage. 1997 Nov;6(4):279-87
9417971
Synapse. 2000 Nov;38(2):138-43
11018787
J Neurosci. 1997 Jan 1;17(1):438-58
8987769
J Neurochem. 1989 Aug;53(2):655-7
2568407
Neuropsychopharmacology. 1993 Dec;9(4):271-5
8305127
Neuroimage. 2006 May 15;31(1):139-52
16469510
J Neural Transm (Vienna). 2001;108(11):1283-98
11768627
Eur J Neurosci. 1999 Mar;11(3):1011-36
10103094
Clin Neurophysiol. 2001 Aug;112(8):1367-77
11459676
Psychopharmacology (Berl). 2005 Nov;182(3):375-83
16001106
Neuroimage. 2004 Jun;22(2):794-803
15193608
Eur J Neurosci. 2001 Oct;14(8):1405-11
11703468
Neuropharmacology. 2004;47 Suppl 1:3-13
15464121
Psychopharmacology (Berl). 2000 Jun;150(2):132-40
10907666
Neuroimage. 1996 Dec;4(3 Pt 1):153-8
9345505
Neuropsychologia. 2008;46(7):2056-63
18336847
Annu Rev Neurosci. 1986;9:357-81
3085570
Psychiatry Res. 2007 Oct 15;156(1):69-74
17683918